US WorldMeds

US WorldMeds, a specialty pharmaceutical company, was founded in 2001 with the vision of CEO Paul Breckinridge "Breck" Jones to improve the lives of patients with challenging conditions. The company focuses on developing, licensing, and bringing to market unique healthcare products to address unmet medical needs. With a strong dedication to serving patients, the company works on bringing new therapies and indications across multiple therapeutic areas. US WorldMeds' commitment to improving patients' lives is reflected in its culture, which values honesty, creativity, integrity, passion for success, and stewardship of company resources. The company's last investment was a Venture Round investment in 01 July 2016 led by CRG. The company's headquarters is located in Louisville, Kentucky, with a presence across the U.S. and globally. US WorldMeds offers a fast-paced environment emphasizing innovation and achievement, providing employees with unique opportunities and exciting challenges. For more information about the company's mission and values, visit their website: http://www.usworldmeds.com, or follow them on Twitter at @USWorldMeds.